Pyridam Farma Tbk PT
IDX:PYFA

Watchlist Manager
Pyridam Farma Tbk PT Logo
Pyridam Farma Tbk PT
IDX:PYFA
Watchlist
Price: 206 IDR -4.63% Market Closed
Market Cap: 2.3T IDR
Have any thoughts about
Pyridam Farma Tbk PT?
Write Note

Pyridam Farma Tbk PT
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pyridam Farma Tbk PT
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Pyridam Farma Tbk PT
IDX:PYFA
Cash from Operating Activities
Rp96.5B
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
N/A
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Cash from Operating Activities
Rp1.5T
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
15%
Kalbe Farma Tbk PT
IDX:KLBF
Cash from Operating Activities
Rp5T
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
10%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Cash from Operating Activities
Rp319.7B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Soho Global Health Tbk PT
IDX:SOHO
Cash from Operating Activities
Rp211.1B
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Cash from Operating Activities
Rp582.4B
CAGR 3-Years
35%
CAGR 5-Years
N/A
CAGR 10-Years
9%
No Stocks Found

Pyridam Farma Tbk PT
Glance View

Market Cap
2.3T IDR
Industry
Pharmaceuticals

PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.

PYFA Intrinsic Value
113.32 IDR
Overvaluation 45%
Intrinsic Value
Price

See Also

What is Pyridam Farma Tbk PT's Cash from Operating Activities?
Cash from Operating Activities
96.5B IDR

Based on the financial report for Sep 30, 2024, Pyridam Farma Tbk PT's Cash from Operating Activities amounts to 96.5B IDR.

What is Pyridam Farma Tbk PT's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
46%

Over the last year, the Cash from Operating Activities growth was -41%.

Back to Top